Scientific Committee on Post-Market Surveillance of COVID-19 Vaccines (CSV-Covid19)

On 14 December 2020, AIFA established a scientific committee for the post-marketing surveillance of COVID-19 vaccines (CSV-Covid19).
The CSV-Covid19 will remain in office for two years and may be renewed.

The Scientific Committee is assigned the objective of coordinating pharmacovigilance activities and collaborating on the Covid-19 epidemic vaccination plan, performing a strategic scientific support function for AIFA, the Ministry of Health and the NHS.

The tasks assigned are:

examine the objectives and methods used in AIFA-supported pharmacovigilance projects;
make recommendations to AIFA on strategic orientations to ensure the safety and pursue the effectiveness of vaccination activities in the country;
indicate the need for specific in-depth studies and make proposals for supplementary studies or the reorientation of current studies;
promote participation in and cooperation with the activities of other support groups with similar tasks in the European and international arena;
collaborate with the CTS in the overall assessment of the overlap between the different vaccines.

AIFA meets

On 12 September, the 'AIFA Incontra' initiative was held at the agency's institutional headquarters in Via del Tritone, a new way of dialogue in transparency

Special Commission Update No. 3 - Towards the reform of the governance of the Italian Medicines Agency and the Single Commission: where are we?

Update 20 November 2023 The extraordinary State-Regions Conference held on 16 November 2023 sanctioned the long-awaited agreement on the Minister of Health's draft regulation,

Towards the reform of governance of the Italian Medicines Agency and the Single Committee

This is our English version of the analysis 'Towards the reform of governance of the Italian Medicines Agency and the Single Committee' produced in collaboration